Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000509460) titled 'A randomised diagnostic imaging trial of [18F]FCH PET/CT vs conventional imaging for primary hyperparathyroidism' on May 23.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Type of endpoint: Efficacy
Primary Sponsor: Queensland Health Metro North Hospital and Health Service
Condition:
primary hyperparathyroidism
primary hyperparathyroidism
Metabolic and Endocrine - Other endocrine disorders
Intervention:
We will enrol eligible patients referred to the Endocrine Surgery department at one acute tertiary hospital site, the R...